This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Madrigal Pharmaceuticals, Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Dominic Labriola in Treating Fatty Liver Disease
Introduction
Dominic Labriola is an accomplished inventor based in Belmar, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of fatty liver diseases. His innovative approach has the potential to improve the lives of many individuals suffering from these conditions.
Latest Patents
Dominic Labriola holds 1 patent for his work titled "Methods for treating a fatty liver disease." This patent outlines a method for treating non-alcoholic steatohepatitis (NASH) in human subjects. The treatment involves the use of a compound known as resmetirom, which has shown promise in improving liver fibrosis in patients.
Career Highlights
Labriola is currently associated with Madrigal Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work focuses on innovative solutions for liver diseases, contributing to the broader field of hepatology.
Collaborations
One of his notable collaborators is Rebecca Taub, with whom he has worked closely to further their research initiatives.
Conclusion
Dominic Labriola's contributions to the treatment of fatty liver disease exemplify the impact of innovation in medicine. His work not only highlights the importance of research but also the potential for new therapies to change lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile